COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

Star tracking across the pharmaverse

While the COVID-19 menace has wreaked havoc across global industries, pharma’s commitment to logistical zeal has provided a supersonic slipstream to optimal performance, not to mention salvation for millions of patients
Data – the key to reshaping patient pathways

Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
Artificial inventors

The question of artificial intelligence as an inventor – and what it means for drug discovery

News

View all

Colchicine added to UK’s COVID-19 ‘RECOVERY’ trial

Commonly used anti-inflammatory drug added to list of potential treatments

30th November 2020

Researchers warn pandemic could delay cancer advances ‘by almost a year’

Survey included input from scientists at The Institute of Cancer Research, London

30th November 2020

Dupixent approved in EU for atopic dermatitis in children

First biologic to be approved for children aged six to 11 years with condition

30th November 2020

UK secures another two million doses of Moderna’s COVID-19 vaccine

New agreement takes supply up to seven million doses in total

30th November 2020

Symkevi/Kalydeco cleared for use in young CF patients

The combination is the first available to treat the underlying cause of CF in this patient group.

27th November 2020

Web Exclusives

View all

Working together

Why combining expertise from the NHS and pharmaceutical experts will deliver better patient outcomes

Now or never

The security of our medicines supply chain matters

A prime target

How can pharma protect itself from cyber criminals?

Pharmacovigilance in a pandemic world

Infusing automation into pharmacovigilance for COVID-19 treatments

Magazine

View more from the latest edition

Patient Files: Spinal muscular atrophy (SMA)

Cheryl Yoder shares her family’s experiences with this rare, genetic disorder

Branching out

Pharma companies have improved how they engage with healthcare providers during COVID-19, says Accenture’s Brad Michel

Decentralising research

Revolutionising clinical trials with wearables and digital endpoints

Reinventing patient engagement

Lessons from the Patient Partnership Index conference

Artificial inventors

The question of artificial intelligence as an inventor – and what it means for drug discovery

Keeping trial data alive

Insight into the conduct of clinical trials and managing data amid the pandemic

Maintaining cross-border medicines supply

Updated guidelines from the European Medicines Agency for pharmaceuticals marketing authorisation holders offer new clarity on what they must do to maintain continuity of supply of UK-registered products in Europe once the Brexit transition period ends.